0 CHECKOUT

Cell-based Assays Market by Product, Applications, End User, & Region - Global Forecast to 2020

  • ID: 3456809
  • November 2015
  • Region: Global
  • 178 Pages
  • Markets and Markets
1 of 5
The Global Cell-Based Assays Market is Expected to Reach USD 18,329.37 Million by 2020 from USD 10,799.53 Million in 2015, Growing at a CAGR of 11.16% Between 2015 and 2020

FEATURED COMPANIES

  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Merck & Co., Inc.
  • Perkinelmer, Inc.
  • MORE

"Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020"

The global cell-based assays market is expected to reach USD 18,329.37 million by 2020 from USD 10,799.53 million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. The product segments included in this report are consumables, instruments, services and software. The consumables segment is further divided on the basis of type into reagents and assay kits, cell lines, micro plates. Reagents and assay kits segment is further divided into reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays. Cell lines segment is further classified into immortalized cell lines, primary cell lines and stem cell lines. On the basis of applications; the report is segmented into basic research, drug discovery, predictive toxicology, ADME studies and other applications. The drug discovery had the largest share of the cell-based assays market in 2015. The predictive toxicology is expected to READ MORE >

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Merck & Co., Inc.
  • Perkinelmer, Inc.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Lucrative Opportunities in the Cell-Based Assays Market
4.2 Life Cycle Analysis, by Region

5 Market Overview
5.1 Introduction
5.1.1 by Product
5.1.2 by Application
5.1.3 by End User
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in R&D Investments
5.2.1.2 Government Funding and Public-Private Partnerships Supporting Cell-Based Research Activities
5.2.1.3 Advantages of Cell-Based Assays Over Prevalent Technologies
5.2.1.4 Drug Discovery, a Major Driver for the Cell-Based Assays Market
5.2.2 Restraints
5.2.2.1 High Instrument Costs
5.2.2.2 Stringent Regulatory Policies
5.2.2.3 Intellectual Property Rights Issues Restricting Innovations in the Market
5.2.3 Opportunities
5.2.3.1 Asian Region Offers High-Growth Opportunities
5.2.3.2 Developments in High-Content Screening and Software to Transform Cell-Based Screening
5.2.4 Trends
5.2.4.1 Label-Free Technologies Are Set to Transform the Market

6 Cell-Based Assays Market, by Product
6.1 Introduction
6.2 Consumables
6.2.1 Reagents & Assay Kits
6.2.1.1 Reporter Gene Assays
6.2.1.2 Second Messenger Assays
6.2.1.3 Cell Growth Assays
6.2.1.4 Cell Death Assays
6.2.1.5 Other Assays
6.2.2 Microplates
6.2.3 Cell Lines
6.2.3.1 Immortalized Cell Lines
6.2.3.2 Primary Cell Lines
6.2.3.3 Stem Cell Lines
6.2.4 Other Consumables
6.3 Instruments
6.4 Services
6.5 Software

7 Cell-Based Assays Market, by Application
7.2 Introduction
7.3 Drug Discovery
7.4 Basic Research
7.5 Adme Studies
7.6 Predictive Toxicology
7.7 Other Applications

8 Cell-Based Assays Market, by End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Government Institutions
8.4 Contract Research Organizations
8.5 Other End Users

9 Cell-Based Assays Market, by Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of the World (Row)

10 Competitive Landscape
10.1 Introduction
10.2 Strategic Overview
10.3 Market Share Analysis
10.4 Competitive Situation and Trends
10.4.1 New Product Launches
10.4.2 Acquisitions
10.4.3 Collaborations and Agreements
10.4.4 Expansions
10.4.5 Other Developments

11 Company Profiles
11.1 Introduction
11.2 Becton, Dickinson and Company
11.3 Cell Signaling Technology, Inc.
11.4 Cisbio Bioassays
11.5 Danaher Corporation
11.6 Discoverx Corporation
11.7 General Electric Company
11.8 Merck & Co., Inc.
11.9 Perkinelmer, Inc.
11.10 Promega Corporation
11.11 Thermo Fisher Scientific, Inc.
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing Rt: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

List of Tables:
Table 1 Cell-Based Assays Market Summary
Table 2 Increasing Healthcare Expenditure: the Primary Driver for the Growth of the Cell-Based Assays Market
Table 3 Market Growth Restrained by High Instrument Costs
Table 4 Emerging Economies Present Significant Growth Opportunities
Table 5 Label-Free Technologies Are An Important Market Trend
Table 6 Cell-Based Assays Market Size, by Product, 2013-2020 (USD Million)
Table 7 Cell-Based Assays Market Size for Consumables, by Region, 2013-2020 (USD Million)
Table 8 Cell-Based Assays Market Size for Consumables, by Type, 2013-2020 (USD Million)
Table 9 Cell-Based Assays Market Size for Reagents & Assay Kits, by Region, 2013-2020 (USD Million)
Table 10 Cell-Based Assays Market for Reagents & Assay Kits, by Type, 2013-2020 (USD Million)
Table 11 Cell-Based Assays Market Size for Reporter Gene Assays, by Region, 2013-2020 (USD Million)
Table 12 Cell-Based Assays Market Size for Second Messenger Assays, by Region, 2013-2020 (USD Million)
Table 13 Cell-Based Assays Market Size for Cell Growth Assays, by Region, 2013-2020 (USD Million)
Table 14 Cell-Based Assays Market Size for Cell Death Assays, by Region, 2013-2020 (USD Million)
Table 15 Cell-Based Assays Market Size for Other Assays, by Region, 2013-2020 (USD Million)
Table 16 Cell-Based Assays Market Size for Microplates, by Region, 2013-2020 (USD Million)
Table 17 Cell-Based Assays Market Size for Cell Lines, by Region, 2013-2020 (USD Million)
Table 18 Cell-Based Assays Market for Cell Lines, by Type, 2013-2020 (USD Million)
Table 19 Cell-Based Assays Market Size for Immortalized Cell Lines, by Region, 2013-2020 (USD Million)
Table 20 Cell-Based Assays Market Size for Primary Cell Lines, by Region, 2013-2020 (USD Million)
Table 21 Cell-Based Assays Market Size for Stem Cell Lines, by Region, 2013-2020 (USD Million)
Table 22 Cell-Based Assays Market Size for Other Consumables, by Region, 2013-2020 (USD Million)
Table 23 Cell-Based Assays Market Size for Instruments, by Region, 2013-2020 (USD Million)
Table 24 Cell-Based Assays Market Size for Services, by Region, 2013-2020 (USD Million)
Table 25 Cell-Based Assays Market Size for Software, by Region, 2013-2020 (USD Million)
Table 26 Cell-Based Assays Market Size, by Application, 2013-2020 (USD Million)
Table 27 Cell-Based Assays Market Size for Drug Discovery Application, by Region, 2013-2020 (USD Million)
Table 28 Cell-Based Assays Market Size for Basic Research Application, by Region, 2013-2020 (USD Million)
Table 29 Cell-Based Assays Market Size for Adme Studies Application, by Region, 2013-2020 (USD Million)
Table 30 Cell-Based Assays Market Size for Predictive Toxicology Application, by Region, 2013-2020 (USD Million)
Table 31 Cell-Based Assays Market Size for Other Applications, by Region, 2013-2020 (USD Million)
Table 32 Cell-Based Assays Market Size, by End User, 2013-2020 (USD Million)
Table 33 Cell-Based Assays Market Size for Pharmaceutical & Biotechnology Companies, by Region, 2013-2020 (USD Million)
Table 34 Cell-Based Assays Market Size for Academic & Government Institutions, by Region, 2013-2020 (USD Million)
Table 35 Cell-Based Assays Market Size for Contract Research Organizations, by Region, 2013-2020 (USD Million)
Table 36 Cell-Based Assays Market Size for Other End Users, by Region, 2013-2020 (USD Million)
Table 37 Cell-Based Assays Market Size, by Region, 2013-2020 (USD Million)
Table 38 North America: Cell-Based Assays Market Size, by Country, 2013-2020 (USD Million)
Table 39 North America: Cell-Based Assays Market Size, by Product, 2013-2020 (USD Million)
Table 40 North America: Cell-Based Assays Market Size for Consumables, by Type, 2013-2020 (USD Million)
Table 41 North America: Cell-Based Assays Market Size for Reagents & Assay Kits, by Type, 2013-2020 (USD Million)
Table 42 North America: Cell-Based Assays Market Size, by Application, 2013-2020 (USD Million)
Table 43 North America: Cell-Based Assays Market Size, by End User, 2013-2020 (USD Million)
Table 44 U.S.: Cell-Based Assays Market Size, by Product, 2013-2020 (USD Million)
Table 45 U.S.: Cell-Based Assays Market Size for Consumables, by Type, 2013-2020 (USD Million)
Table 46 U.S.: Cell-Based Assays Market Size for Reagents & Assay Kits, by Type, 2013-2020 (USD Million)
Table 47 U.S.: Cell-Based Assays Market Size, by Application, 2013-2020 (USD Million)
Table 48 U.S.: Cell-Based Assays Market Size, by End User, 2013-2020 (USD Million)
Table 49 Canada: Cell-Based Assays Market Size, by Product, 2013-2020 (USD Million)
Table 50 Canada: Cell-Based Assays Market Size for Consumables, by Type, 2013-2020 (USD Million)
Table 51 Canada: Cell-Based Assays Market Size for Reagents & Assay Kits, by Type, 2013-2020 (USD Million)
Table 52 Canada: Cell-Based Assays Market Size, by Application, 2013-2020 (USD Million)
Table 53 Canada: Cell-Based Assays Market Size, by End User, 2013-2020 (USD Million)
Table 54 Europe: Cell-Based Assays Market Size, by Product, 2013-2020 (USD Million)
Table 55 Europe: Cell-Based Assays Market Size for Consumables, by Type, 2013-2020 (USD Million)
Table 56 Europe: Cell-Based Assays Market for Reagents & Assay Kits, by Type, 2013-2020 (USD Million)
Table 57 Europe: Cell-Based Assays Market Size, by Application, 2013-2020 (USD Million)
Table 58 Europe: Cell-Based Assays Market Size, by End User, 2013-2020 (USD Million)
Table 59 Asia: Cell-Based Assays Market Size, by Product, 2013-2020 (USD Million)
Table 60 Asia: Cell-Based Assays Market Size for Consumables, by Type, 2013-2020 (USD Million)
Table 61 Asia: Cell-Based Assays Market Size for Reagents & Assay Kits, by Type, 2013-2020 (USD Million)
Table 62 Asia: Cell-Based Assays Market Size, by Application, 2013-2020 (USD Million)
Table 63 Asia: Cell-Based Assays Market Size, by End User, 2013-2020 (USD Million)
Table 64 ROW: Cell-Based Assays Market Size, by Product, 2013-2020 (USD Million)
Table 65 ROW: Cell-Based Assays Market Size for Consumables, by Type, 2013-2020 (USD Million)
Table 66 ROW: Cell-Based Assays Market Size for Reagents & Assay Kits, by Type, 2013-2020 (USD Million)
Table 67 ROW: Cell-Based Assays Market Size, by Application, 2013-2020 (USD Million)
Table 68 ROW: Cell-Based Assays Market Size, by End User, 2013-2020 (USD Million)
Table 69 Market Developments Between January 2013 and September 2015
Table 70 New Product Launches, Jaunary 2013 to September 2015
Table 71 Acquisitions, Jaunary 2013 to September 2015
Table 72 Collaborations and Agreements, Jaunary 2013 to September 2015
Table 73 Expansions, Jaunary 2013 to September 2015
Table 74 Other Developments, Jaunary 2013 to September 2015

List of Figures:
Figure 1 Cell-Based Assays Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Cell-Based Assays Market Size, by Product, 2015 Vs. 2020 (USD Million)
Figure 8 Consumables Market Size, by Type, 2015 Vs. 2020 (USD Million)
Figure 9 Reagents & Kits Market Size, by Type, 2015 Vs. 2020 (USD Million)
Figure 10 Cell Lines Market Size, by Type, 2015 Vs. 2020 (USD Million)
Figure 11 Cell-Based Assays Market Size, by Application, 2015 Vs. 2020 (USD Million)
Figure 12 Cell-Based Assays Market Size, by End User, 2015 Vs. 2020 (USD Million)
Figure 13 Cell-Based Assays Market Size, by Region, 2015 Vs. 2020 (USD Million)
Figure 14 Global Cell-Based Assays Market to Witness Moderate Growth During the Forecast Period
Figure 15 Pharmaceutical & Biotechnology Companies End-User Segment to Dominate the Cell-Based Assays Market
Figure 16 Asia to Witness Highest Growth Rate During the Forecast Period
Figure 17 Asian Market Showcases Lucrative Growth Opportunities
Figure 18 Cell-Based Assays Market Segmentation: by Product
Figure 19 Cell-Based Assays Market Segmentation: by Application
Figure 20 Cell-Based Assays Market Segmentation: by End User
Figure 21 Increasing R&D Spending Will Drive the Cell-Based Assays Market During the Forecast Period
Figure 22 Increasing R&D Investments Boosting Growth in the Cell-Based Assays Market
Figure 23 Cell-Based Assays Market Segmentation, by Product
Figure 24 Cell-Based Assays Market, by Product, 2015 (USD Million)
Figure 25 North America Accounts for the Largest Share of the Consumables Market in 2015
Figure 26 Cell-Based Assays Market for Consumables, by Type, 2015 Vs. 2020 (USD Million)
Figure 27 Cell-Based Assays Market for Reagents & Assay Kits, by Type, 2015 Vs. 2020 (USD Million)
Figure 28 North America Accounts for the Largest Share of the Instruments Market in 2015
Figure 29 North America Accounts for the Largest Share of the Services Market in 2015
Figure 30 North America Accounts for the Largest Share of the Software Market in 2015
Figure 31 Cell-Based Assays Market Segmentation, by Application
Figure 32 Drug Discovery Accounts for the Largest Application Segment of the Cell-Based Assays Market in 2015
Figure 33 North America to Command the Largest Share of the Drug Discovery Application Segment in 2015
Figure 34 North America to Dominate the Cell-Based Assays Market for Basic Research Application in 2015
Figure 35 North America to Command the Largest Share of the Adme Studies Application Segment in 2015
Figure 36 North America to Command the Largest Share of the Predictive Toxicology Application Segment in 2015
Figure 37 North America to Command the Largest Share of the Other Applications Segment in 2015
Figure 38 Cell-Based Assays Market Segmentation, by End User
Figure 39 Cell-Based Assays Market Size, by End User, 2015 (USD Million)
Figure 40 North America to Dominate the Cell-Based Assays Market for Pharmaceutical & Biotechnology Companies in 2015
Figure 41 Cell-Based Assays Market for Academic & Government Institutions to Witness Highest Growth in Asia Between 2015 and 2020
Figure 42 North America to Dominate the Cell-Based Assays Market for Contract Research Organizations Between 2015 and 2020
Figure 43 Cell-Based Assays Market for Other End Users to Witness Highest Growth in Asia Between 2015 and 2020
Figure 44 Asia to Grow At the Highest Rate in the Cell-Based Assays Market During the Forecast Period
Figure 45 Geographic Snapshot (2015)
Figure 46 North America: Market Snapshot
Figure 47 the U.S. is Estimated to Dominate the North American Cell-Based Assays Market in 2015
Figure 48 Consumables Estimated to be the Largest Product Segment in the North American Cell-Based Assays Market in 2015
Figure 49 Reagents & Assay Kits Estimated to be the Largest Segment in the North American Consumables Market in 2015
Figure 50 Reporter Gene Assays Estimated to be the Largest Segment in the North American Reagents & Assay Kits Market in 2015
Figure 51 Drug Discovery to Account for the Largest Share of the Application Market in North America in 2015
Figure 52 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the End-User Market in North America
Figure 53 Consumables Estimated to be the Largest Product Segment in the U.S. Cell-Based Assays Market in 2015
Figure 54 Reagents & Assay Kits Estimated to be the Largest Segment in the U.S. Consumables Market in 2015
Figure 55 Reporter Gene Assays Estimated to be the Largest Segment in the U.S. Reagents & Assay Kits Market in 2015
Figure 56 Drug Discovery to Account for the Largest Application of the U.S. Cell-Based Assays Market in 2015
Figure 57 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the End-User Market in the U.S.
Figure 58 Consumables Estimated to be the Largest Product Segment in the Cell-Based Assays Market in Canada in 2015
Figure 59 Reagents & Assays Kits Estimated to be the Largest Product Segment in the Consumables Market in Canada in 2015
Figure 60 Reporter Gene Assays Estimated to be the Largest Product Segment in the Reagents & Assay Kits Market in Canada in 2015
Figure 61 Drug Discovery to Account for the Largest Application of the Cell-Based Assays Market in Canada in 2015
Figure 62 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the End-User Market in Canada
Figure 63 Consumables Estimated to be the Largest Product Segment in the European Cell-Based Assays Market in 2015
Figure 64 Reagents & Assay Kits Estimated to be the Largest Segment in the European Consumables Market in 2015
Figure 65 Reporter Gene Assays Estimated to be the Largest Segment in the European Reagents & Assay Kits Market in 2015
Figure 66 Drug Discovery to Account for the Largest Share of the Cell-Based Assays Application Market in Europe in 2015
Figure 67 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Cell-Based Assays End-User Market in Europe
Figure 68 Asia: Market Snapshot
Figure 69 Consumables Estimated to be the Largest Product Segment in the Asian Market in 2015
Figure 70 Reagents & Assay Kits Estimated to be the Largest Segment in the Asian Consumables Market in 2015
Figure 71 Reporter Gene Assays Estimated to be the Largest Segment in the Asian Reagents & Assay Kits Market in 2015
Figure 72 Drug Discovery to Account for the Largest Share of the Cell-Based Assays Applications Market in Asia in 2015
Figure 73 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Cell-Based Assays End-User Market in Asia
Figure 74 Consumables Estimated to be the Largest Product Segment in the ROW Cell-Based Assays Market in 2015
Figure 75 Reagents & Assay Kits Estimated to be the Largest Segment in the ROW Consumables Market in 2015
Figure 76 Reporter Gene Assays Estimated to be the Largest Segment in the ROW Reagents & Assay Kits Market in 2015
Figure 77 Drug Discovery to Account for the Largest Share of the ROW Cell-Based Assays Applications Market in 2015
Figure 78 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the ROW Cell-Based Assays End-User Market
Figure 79 New Products Launches is the Key Growth Strategy Adopted by Players in the Cell-Based Assays Market
Figure 80 Cell-Based Assays Market Share Analysis, by Key Player, 2015
Figure 81 Financial Performances of the Leading Market Players
Figure 82 Company Snapshot: Becton, Dickinson and Company
Figure 83 Company Snapshot: Danaher Corporation
Figure 84 Company Snapshot: General Electric Company
Figure 85 Company Snapshot: Merck & Co., Inc.
Figure 86 Company Snapshot: Perkinelmer, Inc.
Figure 87 Company Snapshot: Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Merck & Co., Inc.
  • Perkinelmer, Inc.
  • MORE

The global cell-based assays market is expected to reach USD 18,329.37 Million by 2020 from USD 10,799.53 Million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. Cell-based assays market refers to a wide range of sensitive and reliable methods for research studies on live cells for basic research-based and commercial applications used in pharmaceutical & biotechnology companies, academic & government institutions and contract research organizations. Increasing R&D spending and advancements in cell-based assay techniques will drive the growth of the market.

This report segments the global cell-based assays market by products, applications and end users. The global market product segments included in the report comprises of consumables, instruments, services and software. The cconsumables segment is further divided on the basis of type into reagents & assay kits, microplates and cell lines. Reagents & assay kits segment is further divided into reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays. Cell lines segment is further classified into immortalized cell lines, primary cell lines and stem cell lines.

The applications included in this report are drug discovery, basic research, predictive toxicology, ADME studies and other applications. The drug discovery had the largest share of the cell-based assays market in 2015. Predictive toxicology is expected to one of the fastest growing applications between 2015 and 2020.

On the basis of end users the global cell-based assays market report is segmented into pharmaceutical and biotechnology companies, academic institutions, CROs and other end users. The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the large number of CROs that offer drug discovery services to serve pharmaceutical and biotechnology companies which ultimately drives cell-based assays market.

The major players in cell-based assays market include Becton, Dickinson and Company (U.S.), Merck & Co, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Cisbio Bioassays (France), DiscoveRx (U.S.), General Electric Company (U.S.), and Promega Corporation (U.S.).

Note: Product cover images may vary from those shown
4 of 5

- Becton, Dickinson and Company
- Cell Signaling Technology, Inc.
- Cisbio Bioassays
- Danaher Corporation
- Discoverx Corporation
- General Electric Company
- Merck & Co., Inc.
- Perkinelmer, Inc.
- Promega Corporation
- Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amgen Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Novartis AG
  • Baxter International Inc.